Health, Vaccines, Lyme Disease, FDA, Medicine.
be done in a transparent fashion,” she says. To address these concerns and make a more effective vaccine, Marconi and his colleagues have targeted an entirely different Osp — OspC. This obviates any need for the much-maligned OspA epitope while delivering immunity with fewer booster shots. Unlike